Chemours Q2 net income $70M vs prior loss; adj EBITDA down 36%

Chemours Co

2024-Q2 EPS reported $0.81 revenue$2,887,000,000

Net sales $1.5B (-6% YoY); net income $70M ($0.46 diluted EPS) vs prior-year net loss $376M ($2.52 loss).
Adjusted net income $57M ($0.38 diluted) and adjusted EBITDA $206M vs $324M in Q2 2023.
Cash from ops -$620M includes $606M from restricted cash used for U.S. Water District Settlement (now complete).
Received permit to expand Teflon™ PFA resin production for semiconductor manufacturing at APM.
Appointed Shane Hostetter as new CFO, enhancing leadership with capital allocation expertise.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.